HLB Investment
Overview
HLB Investment is the financial investment arm of the HLB Group, a South Korean conglomerate focused on biopharmaceuticals and healthcare.
Portfolio Companies
3
Website
hlb.co.krInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Neocannbio | Sep 2023 | Series B | Co-investor |
| Soldoc | Jul 2025 | Series B | Co-investor |
| Arontier | Jul 2024 | Strategic | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is HLB Investment based?
HLB Investment is headquartered in South Korea.
When was HLB Investment founded?
Founding year information for HLB Investment is not publicly available.
How many portfolio companies does HLB Investment have?
HLB Investment has 3 portfolio companies in Caplight's dataset.
What are some companies in HLB Investment's portfolio?
Portfolio companies visible on Caplight include Neocannbio, Soldoc, Arontier.
What was HLB Investment's most recent investment shown here?
HLB Investment's most recent investment in this portfolio sample was in Soldoc in 2025.
What sectors does HLB Investment focus on?
HLB Investment focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure.
What company stages does HLB Investment focus on?
HLB Investment typically invests at the Mid stage.